Fujifilm Irvine workforce cuts; Gates Foundation invests in Africa-made vaccines; Sharp acquires BSM

2023-10-12
疫苗信使RNA临床研究
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls, and more.
This week we saw Fujifilm Irvine Scientific lay off employees across its facilities in California, as well as the Gates Foundation investing $40 million in vaccines for lower- and middle-income countries by leveraging Quantoom Biosciences’ mRNA tech.
We zero in on multiple builds, including eXmoor pharma’s new 65,000 square-foot cell and gene facility in Bristol, UK, as well as China-based Sino Biological launching its first facility in the US for recombinant protein production.
Fujifilm Irvine workforce cuts; Gates Foundation invests in Africa-made vaccines; Sharp acquires BSM
Preview
来源: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。